A First Report on [¹⁸F]FPRGD₂ PET/CT Imaging in Multiple Myeloma

Table 1

Patients’ characteristics ().

Feature	n
Median age (range)
65 (51–79) years	4
Sex
Female	1
Male	3
Mean ± SD BMPC infiltration (%)
48 ± 29%	4
Ig isotype
IgG	4
ISS stage at diagnosis
I	1
III	3
Relapsed MM
Time from diagnosis	2
40 & 58 months
Time from last treatment
35 & 52 months
Prior treatment
Thalidomide-dexamethasone/ASCT	1
Melphalan-prednisone-thalidomide	1
No prior bisphosphonates therapy	4

Ig = immunoglobulin; BMPC = bone marrow plasma cell; ASCT = autologous stem cell transplantation.